Citadel Advisors’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$511K Sell
149,500
-95,100
-39% -$321K ﹤0.01% 9252
2025
Q4
$692K Buy
244,600
+75,900
+45% +$391K ﹤0.01% 8233
2025
Q3
$1.17M Buy
168,700
+7,300
+5% +$51.5K ﹤0.01% 7186
2025
Q2
$955K Sell
161,400
-395,300
-71% -$2.27M ﹤0.01% 7207
2025
Q1
$3.56M Buy
556,700
+5,800
+1% +$55.9K ﹤0.01% 4467
2024
Q4
$6.54M Buy
550,900
+356,300
+183% +$6.07M ﹤0.01% 3541
2024
Q3
$5.39M Sell
194,600
-132,400
-40% -$3.31M ﹤0.01% 3818
2024
Q2
$7.8M Buy
327,000
+80,900
+33% +$1.9M ﹤0.01% 3110
2024
Q1
$4.33M Buy
246,100
+53,200
+28% +$784K ﹤0.01% 4166
2023
Q4
$3.04M Buy
192,900
+138,000
+251% +$1.42M ﹤0.01% 4625
2023
Q3
$472K Sell
54,900
-16,600
-23% -$118K ﹤0.01% 8180
2023
Q2
$564K Sell
71,500
-56,800
-44% -$395K ﹤0.01% 7689
2023
Q1
$956K Buy
128,300
+104,600
+441% +$1.04M ﹤0.01% 6869
2022
Q4
$279K Sell
23,700
-36,400
-61% -$416K ﹤0.01% 9469
2022
Q3
$554K Sell
60,100
-50,200
-46% -$608K ﹤0.01% 8231
2022
Q2
$1.09M Sell
110,300
-394,200
-78% -$7.95M ﹤0.01% 6823
2022
Q1
$17.4M Buy
504,500
+258,200
+105% +$8.38M ﹤0.01% 2146
2021
Q4
$12.3M Buy
246,300
+34,100
+16% +$1.8M ﹤0.01% 2720
2021
Q3
$9.76M Sell
212,200
-118,900
-36% -$4.71M ﹤0.01% 3123
2021
Q2
$9.91M Sell
331,100
-19,600
-6% -$400K ﹤0.01% 3090
2021
Q1
$7.13M Buy
350,700
+334,500
+2,065% +$7.06M ﹤0.01% 3540
2020
Q4
$270K Buy
+16,200
New +$213K ﹤0.01% 9246

Other funds holding ASPN

Citadel Advisors's ASPN Position: Q1 2026 in Review

Citadel Advisors reduced its Aspen Aerogels (ASPN) stake by 33% in Q1 2026, selling an estimated $961K and leaving 581,187 shares worth $1.99M. The position accounts for ﹤0.01% of the portfolio, ranked #6076.

Citadel Advisors first reported a position in ASPN in Q4 2015 and has held it in 25 quarters since. The position peaked at $15M in Q2 2024. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.

  • Citadel Advisors held 581,187 shares of Aspen Aerogels worth $1.99M as of Q1 2026.
  • Citadel Advisors sold 285,031 Aspen Aerogels shares in Q1 2026, an estimated $961K.
  • Aspen Aerogels made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6076 holding.
  • Citadel Advisors first reported a position in Aspen Aerogels in Q4 2015 and has held it in 25 quarters since.
  • Citadel Advisors's Aspen Aerogels position peaked at $15M in Q2 2024.
  • 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.